Cheng-Ming Sun

INSERM

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Nabila Elarouci

Head data management

Institut du Cerveau et de la Moelle Épinière

FRANCE

View details

Maxime Meylan

Dana-Farber Cancer Institute

UNITED STATES

View details

Stefano Caruso

Université de Paris Faculté de Santé

FRANCE

View details

catherine sautes-fridman

Emeritus Professor

Université Paris Descartes

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cheng-Ming Sun

Research Interests

Explore related searches

Contact this professor

Articles (10)

Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma

Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.

B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.

Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer.

B cells and cancer: To B or not to B?

The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression.

BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer.

[Impact of molecular signatures on the choice of systemic treatment for metastatic kidney cancer].

Dendritic cells in the tumor microenvironment: prognostic and theranostic impact.

Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer.

Collaborators (4)

Nabila Elarouci

Maxime Meylan

Stefano Caruso

catherine sautes-fridman

Make your next move.